New discovery reveals cause of high blood pressure
Researchers at Michigan Medicine discovered that the enzyme JMJD3 regulates blood pressure by controlling endothelin receptor expression in smooth muscle cells, with a common genetic variant decreasing JMJD3 levels and increasing hypertension risk. Blocking endothelin receptor A showed potential as a targeted therapy for genetically predisposed individuals, advancing understanding of gene-disease interactions in cardiovascular health.